Tianjin Hanrui Pharmaceutical Co., Ltd.

Main purpose: This study used the phenarenic acid tablets (10 mg) certified by Tianjin Hanrui Pharmaceutical Co., Ltd. as the test preparation and the phenarenic acid tablets (trade name: Keshenda, specification: 10 mg) certified by Bayer AG as the reference preparation to conduct a human bioequivalence test under fasting/postprandial conditions to evaluate the bioequivalence of the test preparation and the reference preparation in healthy subjects. Secondary purpose: To observe the safety of the test preparation and the reference preparation in healthy subjects.